Prescription Value Act
Last action on Jun 2, 2003Referred to the Subcommittee on Health.
Take Action
Summary
Prescription Value Act - Directs the Director of the Agency for Healthcare Research and Quality to: (1) collect scientific evidence regarding the relative clinical appropriateness and cost-effectiveness of prescription drugs frequently used by Medicare and Medicaid beneficiaries; (2) assess the validity and reliability of such evidence; and (3) identify areas of additional research needed to make an objective determination on the clinical appropriateness and cost-effectiveness of such drugs.
Lifecycle of the Bill
No events recorded for this stage yet.